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Primary care
Proactive asthma care in childhood: general practice based
randomised controlled trial
Nicholas J Glasgow, Anne-Louise Ponsonby, Rachel Yates, Justin Beilby, Paul Dugdale
Abstract
Objectives To assess the feasibility and effectiveness
of a general practice based, proactive system of
asthma care in children.
Design Randomised controlled trial with cluster
sampling by general practice.
Setting General practices in the northern region of
the Australian Capital Territory.
Participants 174 children with moderate to severe
asthma who attended 24 general practitioners.
Intervention System of structured asthma care (the
3+ visit plan), with participating families reminded to
attend the general practitioner.
Main outcome measures Process measures: rates for
asthma consultations with general practitioner,
written asthma plans, completion of the 3+ visit
plan; clinical measures: rates for emergency
department visits for asthma, days absent from
school, symptom-free days, symptoms over the past
year, activity limitation over the past year, and
asthma drug use over the past year; spirometric
lung function measures before and after cold air
challenge.
Results Intervention group children had significantly
more asthma related consultations (odds ratio for
three or more asthma related consultations 3.8 (95%
confidence interval 1.9 to 7.6; P = 0.0001), written
asthma plans (2.2 (1.2 to 4.1); P = 0.01), and
completed 3+ visit plans (24.2 (5.7 to 103.2);
P = 0.0001) than control children and a mean
reduction in measurements of forced expiratory
volume in one second after cold air challenge of 2.6%
(1.7 to 3.5); P = 0.0001) less than control children.
The number needed to treat (benefit) for one
additional written asthma action plan was 5 (3 to 41)
children. Intervention group children had lower
emergency department attendance rates for asthma
(odds ratio 0.4 (0.2 to 1.04); P = 0.06) and less speech
limiting wheeze (0.2 (0.1 to 0.4); P = 0.0001) than
control children and were more likely to use a spacer
(2.8 (1.6 to 4.7); P = 0.0001). No differences occurred
in number of days absent from school or
symptom-free day scores.
Conclusions Proactive care with active recall for
children with moderate to severe asthma is feasible in
general practice and seems to be beneficial.
Introduction
General practice includes activity characterised as
“largely organised for the diagnosis and treatment of
acute conditions.”1 Strategies for managing chronic ill-
ness include using explicit guidelines, closer follow up,
and systematic attention to the needs of patients in
terms of information and behavioural change.1
Delivering care in chronic illness requires health
systems to move from a reactive orientation towards a
proactive orientation.
Proactive care (regular review), in conjunction with
written asthma action plans and training in self
management, improves outcomes for adults with
asthma.2 No similar evidence base exists for children
with asthma. Given the high prevalence of asthma in
children,3 evaluating proactive asthma care in this
population is important.
Guidelines endorsing proactive asthma care have
been promoted in Australia in the form of the National
Asthma Council’s six step plan.4 The six step plan has
been adapted for the fee for service environment of
Australian general practice with the introduction of the
3+ visit plan (3+ plan).5 Box 1 summarises the features
of this plan.
Components of the six step plan are scheduled
over three or more general practice visits, with two or
more of these visits occurring outside the treatment of
an acute exacerbation. The 3+ plan does not demand
an active recall system. Active recall systems increase
attendance for proactive general practice consulta-
tions.6 We aimed to evaluate the feasibility and
effectiveness of the 3+ plan combined with active recall
in the proactive management of children with moder-
ate to severe asthma.
Methods
The figure summarises the design of the clustered
randomised controlled trial.
Recruitment
Primary schoolchildren in the Australian Capital
Territory received a health survey between February and
April 2000. Children were eligible for recruitment if the
returned questionnaire indicated that they had moder-
ate to severe asthma and a usual general practitioner.
Box 2 summarises how we determined moderate to
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teria,4 from the survey responses. General practitioners
had to have at least three children meeting these criteria
to be included in the trial.
Randomisation
The returned surveys identified usual general practition-
ers and their practices. We enrolled only one general
practitioner in each practice to avoid within practice
contamination. We used SPSS version 10 to randomly
assign 30 eligible practices to control and intervention
groups. Within each practice, we ranked general
practitioners according to the number of children with
moderate to severe asthma and selected the highest
ranking general practitioner from each practice. Twenty
four general practitioners (12 in each group) agreed to
participate. Of 225 children managed by these 24
general practitioners, 175 (78%) consented and
attended the research clinic for baseline assessment at
trial entry. One child withdrew immediately after this
appointment, leaving 101 children in the intervention
arm and 73 in the control arm. No temporal differences
in the recruitment rates by study arm occurred.
Intervention
The chief investigator gave a one to one academic
detailing session to all general practitioners. We asked
control general practitioners to continue their usual
paediatric asthma care and intervention general
practitioners to administer care according to the 3+
plan. We instructed them in the plan and gave them a
3+ plan patient and practitioner resource kit. We
prompted intervention general practitioners when a
child’s next 3+ visit was due. We offered a supplemen-
tary trial information evening separately to each
general practitioner group. We classified a 3+ plan as
fully complete if over the 12 month trial period the
child attended their general practitioner for at least two
asthma related visits, one of which was proactive, and if
each of the two visits showed at least one different 3+
plan content item. We classified 3+ plans as partially
complete if during the same period the child attended
their general practitioner for at least two asthma
related visits, one of which was proactive.
Allocation concealment and consent
We told participants that the study was examining the
effects of reminder systems in proactive care and that
some children would be reminded to return to their
doctor for asthma care. We based this approach on
ethical considerations for cluster randomised trials.7
General practitioners were aware that two study
groups existed but were not informed of their
Box 1: The 3+ visit plan
Visit 1
Often a visit at which the patient presents with an unrelated problem and
does not mention asthma until the end of the consultation. Manage the
issue that caused asthma to be discussed—for example, worsening asthma
symptoms, request for a prescription. Introduce the concept of a “contract”
for care (the 3+ visit plan) and the reasons for review. If the patient presents
solely for an asthma related problem, or it is clinically appropriate and
possible, include the items in visit 2. Give the 3+ visit plan handout to the
patient.
Visit 2
New patient—Ascertain status, including history, drug treatment, and
management.
Existing patient—Assess current situation, including review of medical records
and consolidation or collection of information on history, drug treatment, and
management. What do they know and what do they need to know
(knowledge)? How do they feel about their asthma (perception)? What do
they want from you, the general practitioner? Review inhalation devices and
technique. Do physical examination (including spirometry). Grade severity
and level of control of asthma. Consider two weeks of recording and charting
of peak expiratory flow rate. Is a change in drug needed?
Visit 3 (approximately two weeks later)
Review patient and his or her peak expiratory flow record. Do spirometry
(if not already done, or consider redoing). Complete written asthma action
plan. Further identify trigger factors: consider radioallergosorbent test
(RAST), skin prick tests (if not already done). Is a change in drug needed?
Check on, reinforce, and expand education. Answer any questions.
Visit 4 (approximately four weeks later)
Assess progress. Review asthma action plan. Discuss results of trigger factor
tests (if applicable). Check on, reinforce, and expand education. Answer any
questions.
Box 2: Criteria to determine the presence of moderate to severe
asthma
For a child to have moderate to severe asthma, respondents had to answer
“Yes” to the following item:
• Does your child have asthma?
and then “Yes” to at least one of the following additional items:
• Has your child ever been admitted overnight to intensive care for asthma?
• Have your child’s normal or sports activities been restricted at least one to
three days a week over the past 12 months?
• Has your child experienced wheeze, night cough or night wheeze, or
shortness of breath at least one to three days a week over the past 12
months?
• Has your child used a preventer medication at least one to three days a
week or a reliever medication four or more days a week over the past 12
months?
Survey of 32 142 children in Feb-Mar 2000 to identify
those with moderate to severe asthma and a general practitioner
Eligible 5-12 year old primary school students (n=225)
Eligible general practitioners (n=30)
Consenting children (n=74; 77% of eligible)






















Retention rates at 12 months
Control group
Summary of trial timeline and participant retention rates
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allocation. We assessed concealment at trial end by
asking general practitioners which arm of the trial they
thought they were in. Six control general practitioners
said the control group, and the rest did not know. Six
intervention general practitioners said the control
group, two said the intervention group, and three did
not know.
Data collection
Children attended three assessment clinics during the
trial. These were at trial entry, five to six months, and
trial completion. We administered standard question-
naires, including items from the international study of
asthma and allergies in childhood.8 The children then
had spirometric tests (Fleisch-type electronic spiro-
meter, Vitalograph alpha 2, model AL0642; Vitalo-
graph, Buckingham, UK) before and after a standard
cold air challenge test.9 10
We audited general practitioners’ case notes for all
patients at trial end to assess the number and type of
asthma related visits made by participants to their
nominated general practitioner during the trial period.
For each participant, general practitioners also gave a
verbal report of their written medical records of
asthma related consultations, which two independent
auditors classified into consultation types (table 1).One
auditor was blind to the general practitioners’ study
group allocation, and the other was not. We used the
data of the blinded auditor for all analyses. We carried
forward six month pilot audit data for analysis for two
of the initial general practitioners, one “control” and
one “intervention,” who were unavailable for audit at
trial end because of illness or interstate relocation.
Outcome measures
Study endpoints comprised process, clinical, and
spirometric measures as shown in tables 2, 3, and 4.We
obtained the process and clinical measures by using
questionnaires completed by parents. Spirometric
measures comprised the percentage reduction and
absolute reduction in forced expiratory volume in one
second (FEV1) after cold air challenge.
Statistical methods
We estimated sample sizes by using the approach of
Campbell et al,12 assuming that each general prac-
titioner would have between three and seven children
with asthma. For a power of 80% and a significance
level of 0.05 we needed between 13 and 21 general
practitioners (91 and 63 children) to detect a change
from a baseline rate for a written asthma action plan of
30% to 70% at 12 months.
We compared the children in the intervention and
control groups with respect to study outcomes by using
two by two contingency tables with a 2 test or Fisher’s
exact test. Table 2 summarises the differences in baseline
measures for trial outcomes. The total numbers differ
slightly by variable in tables 3 and 4, because not all par-
ents reported on all variables. We then used generalised
estimating equations with fixed and random compo-
nents with a logit link and a binomial error structure to
provide odds ratios and associated confidence intervals
for the effect of the intervention on the questionnaire
outcomes examined.13 Inclusion of a term for the
baseline value of each outcome ensured that the models
were adjusted for any differences in baseline values that
arose by chance through the randomisation process.We
examined spirometric measures of lung function by
using a generalised estimating equation regression
model, adjusting for the intervention and baseline values
as fixed effects and general practitioners as random
effects.We also estimated the within general practitioner
correlations for each outcome. They ranged from 0.16
(completion of 3+ plan) to − 0.05 with a mean of
− 0.002.We used Stata 6 for intention to treat analyses.
Table 1 Classification of consultation types
Consultation type Definition
Reactive A consultation that occurred because the child had an
exacerbation of asthma symptoms
Proactive A consultation that occurred when the child was well and
involved asthma management
Opportunistic A consultation that occurred for some reason other than
asthma, but during which asthma was addressed
Indeterminate A consultation that could not be assigned to one of the
other three categories
Table 2 Baseline characteristics of general practitioners and children. Values are





30-39 0 1 (8)
40-49 6 (50) 7 (58)
50-59 6 (50) 4 (33)
Men 8 (67) 8 (67)
Children per general practitioner:
1-4 4 (33) 3 (25)
5-9 5 (42) 7 (58)
10-14 3 (25) 1 (8)




5-6 14 (19) 30 (30)
7-8 16 (22) 25 (25)
9-10 26 (36) 33 (33)
11-12 17 (23) 13 (13)
Boys 40 (55) 56 (55)
Outcome measures
General practitioner consultations in past six months:
None 22 (31) 34 (34)
1 18 (25) 29 (29)
2 16 (22) 15 (15)
≥3 16 (22) 23 (23)
Unknown 1 (1) 0
Have a written asthma action plan 20/72 (28) 23 (23)
Attended emergency department 1-3 times in past 12 months 15/67 (22) 14/95 (15)
Did not miss any school days with wheezing or asthma in past 12 months 23/71 (32) 30 (30)
Mean (SD) symptom-free day score* 3.4 (0.9) 3.5 (0.8)
Mean (SD) percentage change in FEV1 after cold air challenge† −0.7 (4.9) −2.2 (6.3)
Mean (SD) absolute difference (ml) in FEV1 after cold air challenge† −14 (88) −36 (109)
Four or more episodes of wheeze in past 12 months 35/71 (49) 46/100 (46)
Wheeze severe enough to limit speech to one or two words in past 12 months 15/72 (21) 17 (17)
Normal activities restricted by respiratory symptoms in past 12 months 6/71 (8) 7/98 (7)
Sports or exercise activities restricted by respiratory symptoms in past
12 months
9/71 (13) 16/100 (16)
Uses preventers more than four days a week on average 40/69 (58) 43/95 (45)
Uses relievers more than four days a week on average 15/69 (22) 14/100 (14)
Uses pressurised metered dose inhalers alone 25/73 (34) 31 (31)
Uses pressurised metered dose inhalers with spacer 45 (62) 66 (65)
Uses nebuliser 29 (40) 36 (36)
FEV1=forced expiratory volume in 1 second.
*1=average of 4+ symptom days/week; 5=no symptom days/week.
†Control group n=69; intervention group n=92.
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Results
Baseline demographics and participation rates
Table 2 summarises the baseline characteristics of the
participating general practitioners and children. The
two groups were similar, but the children in the
intervention group had, on average, greater reductions
in FEV1 after cold air challenge ( − 2.2%) than control
children ( − 0.7%). Four out of 69 (6%) control children
and 13/92 (14%) intervention children had missing
spirometric outcome data at the end of the trial
(P = 0.2). Eight children were lost to follow up, 6/101
(6%) in the intervention group and 2/73 (3%) in the
control group. Four of these children formally
withdrew from the trial (all intervention)—one had
moved interstate, and the remaining three failed to
attend three scheduled visits and did not subsequently
return mailed clinic questionnaires.
Outcome measures at 12 months
Table 3 shows that intervention children attended their
general practitioners for asthma related consultations
more often than control children, and for intervention
children these consultations were significantly more
likely to be proactive. Twenty eight per cent of the chil-
dren in the intervention group fully completed the 3+
plan, significantly more than the 3% in the control
group. An additional 20% of the intervention children
partially completed the 3+ plan. The intervention
group had increased use of written asthma action
plans at 12 months. The number needed to treat (ben-
efit) for one additional written asthma action plan was
5 (95% confidence interval 3 to 41) children.14 Neither
symptom-free day scores nor the three components of
this composite score (wheeze, night time symptoms,
and restriction of activities) differed between groups
(table 4). However intervention children had fewer




(95% CI) P value
Number needed to
treat (benefit)*
(95% CI)Control (n=73) Intervention (n=101)
Process measures
Asthma related visits to general practitioner during trial period† (audit of general practitioner records at trial end):
0 29 (40) 19 (19) 1 (reference) NA NA
1-2 29 (40) 42 (42) 2.1 (1.0 to 4.5) 0.05 NA
≥3 15 (21) 40 (40) 3.8 (1.9 to 7.6) 0.0001 NA
Proactive general practitioner consultations during trial period:
0 59 (81) 46 (46) 1 (reference) NA NA
1-2 8 (11) 24 (24) 3.7 (1.8 to 7.4) 0.0001 NA
≥3 6 (8) 31 (31) 7.3 (2.2 to 23.9) 0.001 NA
Reactive general practitioner consultations during trial period:
0-1 61 (84) 74 (73) 1 (reference) NA NA
2 7 (10) 18 (18) 2.6 (1.3 to 4.9) 0.005 NA
≥3 5 (7) 9 (9) 1.7 (0.7 to 3.8) 0.2 NA
Have written action plan† 24/71 (34) 42/95 (44) 2.2 (1.2 to 4.1) 0.01 5 (3 to 41)
Completed 3+ plan:
No 65 (89) 53 (52) 1 (reference) NA
Partial 6 (8) 20 (20) 3.8 (1.1 to 13.1) 0.04 6 (2 to 146)
Yes 2 (3) 28 (28) 24.2 (5.7 to 103.2) 0.0001 3 (1 to 8)
Clinical measures
Attended emergency department 1-3 times for respiratory
symptoms in past 12 months†
8/71 (11) 4/95 (4) 0.4 (0.2 to 1.04) 0.06 17 (12 to ∞)
Did not miss any school days with wheezing or asthma
in past 12 months†
32/71 (45) 49/95 (52) 0.8 (0.5 to 1.2) 0.3 22 (6 to ∞)
Four or more episodes of wheeze in past 12 months† 24/71 (34) 25/95 (26) 0.6 (0.3 to 1.3) 0.2 11 (5 to ∞)
Wheeze severe enough to limit speech to one or two
words in past 12 months†
13/71 (18) 5/95 (5) 0.2 (0.1 to 0.4) 0.0001 8 (7 to 10)
Normal activities restricted by respiratory symptoms in
past 12 months†
6/71 (8) 3/95 (3) 0.4 (0.06 to 2.1) 0.3 20 (13 to ∞)
Sports or exercise activities restricted by respiratory
symptoms in past 12 months†
10/71 (14) 6/95 (6) 0.4 (0.2 to 1.1) 0.08 14 (9 to ∞)
Uses preventers more than four days a week on average† 31/64 (48) 40/84 (48) 1.9 (0.8 to 4.5) 0.2 6 (3 to ∞)
Uses relievers more than four days a week on average† 19/64 (30) 8/87 (9) 0.3 (0.2 to 0.6) 0.001 6 (4 to 12)
Uses pressurised metered dose inhalers alone† 33/71 (46) 30/95 (32) 0.4 (0.2 to 1.0) 0.04 5 (3 to 150)
Uses pressurised metered dose inhalers with spacer† 27/71 (38) 59/95 (62) 2.8 (1.6 to 4.7) 0.0001 4 (3 to 8)
Uses nebuliser† 24/71 (34) 20/95 (21) 0.5 (0.2 to 1.1) 0.09 7 (4 to ∞)
NA=not applicable.
*Numbers needed to treat (benefit) (NNTB) and corresponding 95% confidence intervals derived from adjusted odds ratios (OR) and 95% confidence intervals and patient expected event rates (PEER)
equal to the proportion observed for the control group. NNTB=1−[PEER×(1−OR)]/[PEER×(1−OR)×(1−PEER)] for OR<1 and NNTB=1+[PEER×(OR−1)]/[PEER×(OR−1)×(1−PEER)] for OR>1.11
†Measures intervention effect taking into account baseline value of the outcome measure.
Table 4 Clinical and spirometric outcome measures at 12 months
Outcome measure
Mean (SD) Mean (95% CI)
treatment effect* P valueControl Intervention
Clinical measures
Symptom-free days score† 3.9 (0.9) 4.1 (0.6) 0.1 (−0.03 to 0.2) 0.1
Spirometric measures‡
Percentage change in FEV1 after
cold air challenge
−2.6 (6.3) −0.5 (5.2) 2.6 (1.7 to 3.5) 0.0001
Absolute difference (ml) in FEV1
after cold air challenge
−57 (159) −9 (89) 44 (18 to 70) 0.001
FEV1=forced expiratory volume in 1 second.
*Measures effect of intervention taking into account baseline value of the outcome measure.
†1=worst (average ≥4 days with symptom each week); 5=best (all days symptom free). Control group,
n=71; intervention group, n=95.
‡Models adjusted for child’s sex, height, weight, and trial entry measurement and to take account of
clustering by general practitioner. Control group, n=67; intervention group, n=82.
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occurrences of speech-limiting wheeze at trial end
(table 3). Intervention children were more likely to use
pressurised metered dose inhalers with a spacer and
less likely to use relievers more than four days each
week. Emergency department attendances tended to
occur less often in intervention children, although the
difference did not reach statistical significance.
Spirometric measurements indicated that the interven-
tion children were significantly less reactive to cold air
than were control children (table 4). This persisted
after further adjustment for clinic temperature and
humidity and presence of an upper respiratory
infection.
Discussion
The combination of the 3+ visit plan with prompts for
children to attend proactive asthma appointments
resulted in improved asthma management. The 3+
plan was much more likely to be completed by
intervention general practitioners, with increased use
of written asthma action plans among intervention
children. Statistically significant, but clinically small,
reductions occurred in the reactivity of intervention
children’s FEV1 measurements to cold air challenge,
supporting the hypothesis that the intervention group
would have better controlled asthma and therefore less
bronchial hyperreactivity after the challenge.15
Although some clinical measures did not show signifi-
cant differences between the control and intervention
groups, a marked reduction in speech-limiting wheeze
occurred and intervention children’s attendance at the
emergency department tended to be lower than that
for control children, with an odds ratio of substantial
magnitude (0.4). This difference approached statistical
significance and represented a number needed to treat
(benefit) of 17, a clinically important finding given the
burden placed on emergency departments by children
with exacerbations of wheeze.4 16
Study strengths and limitations
The findings are strengthened by the randomised con-
trolled design, relatively unusual in studies looking at
the organisation of healthcare delivery.17 Blinding is
difficult to achieve in studies such as this,7 but less than
half of general practitioners correctly identified their
group allocation at trial end, indicating that the
concealment approach used was effective. Retention
rates were high. The study endpoints provided a
balance between process, clinical, and spirometric data,
and the study method was designed to approximate as
closely as possible the “real world” of general practice.
The intervention was not “forced.” General practition-
ers, parents, and children were free to make decisions
about whether a visit actually took place. Even when a
practice was prompted to remind a child to return, the
decision to actually recall that child was made by the
doctor. If a recall was made, parents had a free choice
about whether to attend. The intention to treat
analyses considered all intervention children as a
group regardless of howmuch of the 3+ plan they were
exposed to. After intervention general practitioners
had one face to face academic detailing session and a
dinner meeting discussing the 3+ plan, 52% of the
intervention children received no aspects of the 3+
plan and 20% received only parts of it. This moderate
uptake is consistent with the reported effectiveness of
outreach visits and local opinion leaders as a means of
influencing practice.18 The effect is important, however,
given that 89% of the control children were not
exposed to the 3+ plan at all.
Explanations for the limited uptake of the 3+ plan
by the intervention general practitioners are specula-
tive. They include framing the study question as
general practitioners’ recall rather than the 3+ plan in
order to approximate blinding, the mild nature of
some children’s asthma being appropriately managed
by less structured care, and the difficulty of implement-
ing the 3+ plan approach for all patients despite its
adoption by general practitioners. The last possibility is
likely given that all but two intervention general practi-
tioners completed the 3+ plan for at least one child in
their care, yet the overall completion rate for the 3+
plan was low.
Two aspects of the study potentially reduced its
power. Firstly, the study relied on survey results to iden-
tify children with moderate to severe asthma. Although
we used criteria taken from existing guidelines,4 the chil-
dren’s spirometric assessments at trial entry produced
mean changes in FEV1 after cold air challenge of less
than 3% in both arms, much less than the 9% identified
by Nicolai et al as the 95th centile cut-off point between
the reference population and children with excess bron-
chial hyperreactivity.9 Secondly, the children’s asthma
status changed over time: although all children satisfied
the criteria in March 2000, the same questionnaires
given at trial entry (May 2000), round 2 (October 2000),
and round 3 (July 2001) identified 76%, 64%, and 53% of
children as having moderate to severe asthma. Thus, this
study is likely to have included children with mild
disease who needed neither additional general prac-
titioner visits nor completion of the 3+ plan for optimal
management.
Measurement of process
Written asthma plans represent one facet of optimal
asthma care and are a specific content item in the 3+
plan.2 In eastern Australia 21.7% of children reported
having a written asthma action plan in 1993, an
increase from 16.7% in 1990.19 Here, at trial end, 44%
of intervention children had a written asthma action
plan, less than the 70% used to estimate sample sizes.
However, this is still an important outcome, with five
children needing the intervention to provide one addi-
tional written asthma action plan.
Measurement of completion of the 3+ plan was
complex and needed three criteria to be satisfied. Con-
sultations had to occur in which asthma was
considered; at least one of these consultations had to
be proactive; and at least two different content items
from the 3+ plan had to be covered. This approach led
to the apparent paradox that the 3+ plan could be
completed in two visits for the purposes of this study.
The 3+ plan was designed for delivery over three or
more consultations to allow for a usual consultation
being about 10-15 minutes long, rather than because
of evidence that three or more consultations were ben-
eficial. General practitioners may have taken more
time on occasions and delivered more than one
consultation’s “worth” of 3+ plan materials. The 3+
plan approach was nationally promoted during the
course of the trial, and this could explain the fact that
Primary care
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some control children received it. The idea of regular
review is part of optimal asthma management, so
allowing completion of the 3+ plan in a single consul-
tation was inappropriate. Proactive consultations
allowed time for observation of inhaler technique,
review of a written asthma action plan, or development
of a child’s understanding of asthma. The measured
clinical and spirometric changes reflect both full and
partial exposure to the intervention. In keeping with
trends in delivering primary care, the 3+ plan allows
for content items to be delivered by nurses, asthma
educators, or both, where such resources are available.
The focus of this trial was on general practitioners
undertaking proactive care, rather than on assessing
the contributions made by different members of the
primary healthcare team.
Several possibilities may explain the excess of reac-
tive visits seen in the intervention group. These
children may have had more symptoms as a result of
chance. An imbalance between the control and
intervention groups in terms of reactive care could
have existed at the start of the trial. This could not be
assessed, as we did no baseline audit of the general
practice records. Parents of intervention children may
have had a greater awareness of asthma symptoms,
because of the proactive consultations, and therefore a
lower threshold for presenting. The classification of
consultation type is unlikely to have introduced bias, as
the auditor was blind to trial group status.
Child related outcomes
Although most of the clinical outcomes showed
beneficial effects in the intervention group, two impor-
tant clinical indicators of childhood asthma control
showed no change in the study—the symptom-free day
scores and the number of days missed from school
with asthma. For both these items, parents were asked
to recall the information at the time of clinic visits. The
approach chosen may have lacked sufficient sensitivity
to detect true differences. We used the same method
for speech-limiting wheeze and emergency depart-
ment visits, but these dramatic events may be more
likely to be accurately recalled. Alternatively, the inter-
vention may have had a stronger impact on more
severe asthma. The direction of change for all clinical
measures favoured the intervention arm. Intervention
children were less likely to use pressurised metered
dose inhalers alone and more likely to use pressurised
metered dose inhalers with a spacer device. Non-
significant trends favouring the intervention children
occurred: the daily use of preventer drugs increased,
quality of life factors such as activity restriction because
of wheeze improved,20 and the frequency of episodes of
wheeze decreased. Part of the reduction in symptom
scores and visits to the emergency department could
plausibly result from improved adherence to preventer
drug regimens using optimised delivery systems.
We chose cold air spirometry as the challenge test
because it is acceptable to children and represents a
“natural” wintertime exposure.9 21 The magnitude of
the reduction in reactivity to cold air was small for
intervention children. The spirometric test results have
little clinical importance in isolation but give useful
construct validity, providing reassurance that the effect
of the intervention was not just dissuading parents
from presenting to an emergency department or
encouraging parents to under-report symptoms.
Conclusion
These results suggest that the 3+ visit plan combined
with recall in children with asthma results in improved
asthma management with a reduction in respiratory
morbidity. Confirming the effect of the 3+ plan
combined with recall on emergency department pres-
entations and examining the effects of this approach in
adolescent and adult populations are important future
studies.
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